Literature DB >> 20640923

[Oral anticoagulation and risk of bleeding in elderly patients - the aspect of polypharmacy].

Regina E Roller1, Bernhard Iglseder2, Peter Dovjak3, Monika Lechleitner4, Ulrike Sommeregger5, Ursula Benvenuti-Falger4, Ronald Otto6, Birgit Böhmdorfer5, Markus Gosch4.   

Abstract

Oral anticoagulant therapy has been shown to be of benefit also in elderly patients in various therapeutic and prophylactic indications. Despite strong evidence in literature, doctors still refuse to prescribe oral anticoagulants to geriatric patients in daily routine. Main reason for this decision is the fear of secondary bleeding complications. According to clinical trial data, distinct risk factors for bleeding attributed to anticoagulant treatment may be determined: age >70 years, female gender, recurrent bleeding events, alcohol/drug abuse, diabetes, anaemia and polypharmacy. The entire article reveals the literature in Medline and Cochrane Library from 1980 to 2009 including the hits "polypharmacy - anticoagulant treatment - elderly patients". It further highlights risk assessment strategies in elderly patients, and possible pharmacokinetic and -dynamic interactions of drugs co-administered with oral anticoagulants.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20640923     DOI: 10.1007/s10354-010-0785-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  21 in total

Review 1.  Oral anticoagulants. Pharmacologic issues for use in the elderly.

Authors:  E M Hylek
Journal:  Clin Geriatr Med       Date:  2001-02       Impact factor: 3.076

Review 2.  Interaction of warfarin with drugs, natural substances, and foods.

Authors:  David J Greenblatt; Lisa L von Moltke
Journal:  J Clin Pharmacol       Date:  2005-02       Impact factor: 3.126

Review 3.  Self-monitoring of oral anticoagulation: a systematic review and meta-analysis.

Authors:  C Heneghan; P Alonso-Coello; J M Garcia-Alamino; R Perera; E Meats; P Glasziou
Journal:  Lancet       Date:  2006-02-04       Impact factor: 79.321

4.  Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism.

Authors:  P M Kuijer; B A Hutten; M H Prins; H R Büller
Journal:  Arch Intern Med       Date:  1999-03-08

5.  Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study.

Authors:  G Palareti; J Hirsh; C Legnani; C Manotti; A D'Angelo; V Pengo; M Moia; G Guazzaloca; S Musolesi; S Coccheri
Journal:  Arch Intern Med       Date:  2000-02-28

6.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G De Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

7.  Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.

Authors:  R J Beyth; L M Quinn; C S Landefeld
Journal:  Am J Med       Date:  1998-08       Impact factor: 4.965

8.  Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants.

Authors:  F J van der Meer; F R Rosendaal; J P Vandenbroucke; E Briët
Journal:  Thromb Haemost       Date:  1996-07       Impact factor: 5.249

9.  The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics.

Authors:  S D Fihn; C M Callahan; D C Martin; M B McDonell; J G Henikoff; R H White
Journal:  Ann Intern Med       Date:  1996-06-01       Impact factor: 25.391

10.  Safety of anticoagulation therapy in well-informed older patients.

Authors:  Nadya Kagansky; Hilla Knobler; Ephraim Rimon; Zinaida Ozer; Shmuel Levy
Journal:  Arch Intern Med       Date:  2004-10-11
View more
  4 in total

1.  Are the elderly different? Factors influencing mortality after percutaneous coronary intervention with stent implantation.

Authors:  J Schröder; U Müller-Werdan; S Reuter; A Vogt; M Schlitt; U Raaz; I Reindl; M Buerke; K Werdan; A Schlitt
Journal:  Z Gerontol Geriatr       Date:  2013-02       Impact factor: 1.281

2.  [Thrombosis prophylaxis in geriatric patients].

Authors:  R E Roller; P Feichtinger
Journal:  Z Gerontol Geriatr       Date:  2012-04       Impact factor: 1.281

Review 3.  Stress ulcer prophylaxis, thromboprophylaxis and coagulation management in patients with hip fractures.

Authors:  Heinrich Wolfgang Thaler; Peter Dovjak; Bernhard Iglseder; Georg Pinter; Ernst Müller; Walter Müller; Katharina Pils; Peter Mikosch; Inge Gerstorfer; Michaela Zmaritz; Monique Weissenberger-Leduc; Markus Gosch
Journal:  Wien Med Wochenschr       Date:  2013-09-04

4.  Effects of age and sex on the single-dose pharmacokinetics and pharmacodynamics of apixaban.

Authors:  Charles E Frost; Yan Song; Andrew Shenker; Jessie Wang; Yu Chen Barrett; Alan Schuster; Stuart I Harris; Frank LaCreta
Journal:  Clin Pharmacokinet       Date:  2015-06       Impact factor: 6.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.